Epidemiology of colorectal cancer: A review with special emphasis on India.

Samyukta Shivshankar, Prachi S Patil, Kedar Deodhar, Atul M Budukh
Author Information
  1. Samyukta Shivshankar: Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, 400 094, India. ORCID
  2. Prachi S Patil: Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, 400 094, India. ORCID
  3. Kedar Deodhar: Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, 400 094, India. ORCID
  4. Atul M Budukh: Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, 400 094, India. budukham@tmc.gov.in. ORCID

Abstract

Colorectal cancer (CRC) is a common malignancy and cause for death around the world. In India, it ranks as the fourth most incident cancer in both sexes, with 64,863 cases and 38,367 deaths in 2022. With such high mortality, CRC survival in India is way lesser than that of developed countries. While western countries are facing an overall decline in CRC incidence, various regions in India are seeing an increasing trend. Within India, urban regions have markedly higher incidence than rural. Risk factors include consumption of red and processed meat, fried and sugary food, smoking and alcohol, comorbidities such as obesity, diabetes and inflammatory bowel disease (IBD), family history of CRC, adenomas and genetic syndromes, radiation exposure, pesticides and asbestos. Consumption of nutrient-rich well-balanced diets abundant in vegetables, dairy products, whole grains, nuts and legumes combined with physical activity are protective against CRC. Besides these, metformin, aspirin and micronutrient supplements were inversely associated with the development of CRC. Since a considerable proportion of CRC burden is attributed to modifiable risk factors, execution of population level preventive strategies is essential to limit the growing burden of CRC. Identifying the necessity, in this review, we explore opportunities for primary prevention and for identifying high-risk populations of CRC to control its burden in the near future.

Keywords

References

  1. Front Oncol. 2022 May 25;12:812679 [PMID: 35692761]
  2. Ann Oncol. 2017 Aug 01;28(8):1788-1802 [PMID: 28407090]
  3. Eur J Epidemiol. 2022 Jun;37(6):569-585 [PMID: 35622305]
  4. Br J Cancer. 2021 Dec;125(12):1726-1733 [PMID: 34593992]
  5. United European Gastroenterol J. 2017 Aug;5(5):708-714 [PMID: 28815035]
  6. Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2309-2322 [PMID: 32855265]
  7. Int J Epidemiol. 2020 Oct 1;49(5):1540-1552 [PMID: 32814947]
  8. Indian J Surg Oncol. 2017 Dec;8(4):484-490 [PMID: 29203978]
  9. Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):565-8 [PMID: 19827870]
  10. J Am Coll Nutr. 2015;34(6):521-43 [PMID: 25941850]
  11. Medicine (Baltimore). 2023 Mar 10;102(10):e33177 [PMID: 36897722]
  12. Br J Cancer. 2022 Apr;126(6):957-967 [PMID: 34921228]
  13. Gut Microbes. 2023 Jan-Dec;15(1):2185028 [PMID: 36927206]
  14. BMC Public Health. 2023 Jul 19;23(1):1386 [PMID: 37468880]
  15. J Natl Cancer Inst. 2017 Aug 1;109(8): [PMID: 28376186]
  16. BMC Med. 2023 Jan 4;21(1):5 [PMID: 36600297]
  17. Cancer Causes Control. 2013 Jun;24(6):1207-22 [PMID: 23563998]
  18. Nutr Cancer. 2023;75(5):1281-1294 [PMID: 36961108]
  19. Am J Clin Nutr. 2022 Jun 7;115(6):1481-1489 [PMID: 35470384]
  20. Chemosphere. 2021 May;271:129596 [PMID: 33460900]
  21. Oncotarget. 2016 Nov 22;7(47):76735-76742 [PMID: 27732934]
  22. Front Nutr. 2021 Jul 12;8:688897 [PMID: 34322510]
  23. BMJ. 2021 May 4;373:n877 [PMID: 33947661]
  24. Int J Environ Res Public Health. 2021 Aug 16;18(16): [PMID: 34444406]
  25. Sci Rep. 2017 Jan 16;7:40363 [PMID: 28091607]
  26. Cancer Sci. 2017 May;108(5):1065-1070 [PMID: 28256076]
  27. Indian J Surg Oncol. 2022 Sep;13(3):446-452 [PMID: 36187542]
  28. Asia Pac J Public Health. 2016 Jul;28(5):394-403 [PMID: 27217428]
  29. Prev Med. 2017 Dec;105:345-349 [PMID: 28987338]
  30. World J Gastroenterol. 2014 Sep 21;20(35):12431-44 [PMID: 25253943]
  31. Cancers (Basel). 2021 Jun 04;13(11): [PMID: 34200111]
  32. Colorectal Dis. 2018 Nov;20(11):961-969 [PMID: 30199598]
  33. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):627-647 [PMID: 35397795]
  34. J Cancer Prev. 2015 Jun;20(2):147-52 [PMID: 26151048]
  35. Viruses. 2020 Jan 14;12(1): [PMID: 31947702]
  36. Hematol Oncol Clin North Am. 2022 Jun;36(3):393-414 [PMID: 35501176]
  37. Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):288-299 [PMID: 31767566]
  38. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):127-35 [PMID: 19910129]
  39. Nutrients. 2017 Sep 20;9(9): [PMID: 28930191]
  40. World J Gastrointest Oncol. 2016 Feb 15;8(2):207-14 [PMID: 26909135]
  41. Cancer Epidemiol. 2021 Aug;73:101973 [PMID: 34198235]
  42. Int J Cancer. 2013 Mar 15;132(6):1404-11 [PMID: 22821300]
  43. ANZ J Surg. 2023 Jun;93(6):1480-1486 [PMID: 36757832]
  44. Med J Aust. 2016 Nov 21;205(10):465-470 [PMID: 27852185]
  45. JAMA Netw Open. 2023 Nov 1;6(11):e2343333 [PMID: 37962884]
  46. BMC Cancer. 2024 Mar 6;24(1):308 [PMID: 38448839]
  47. BMC Med. 2022 Nov 29;20(1):430 [PMID: 36443779]
  48. Indian J Community Med. 2021 Jul-Sep;46(3):474-478 [PMID: 34759491]
  49. Int J Cancer. 2015 May 15;136(10):2388-401 [PMID: 25335850]
  50. J Natl Cancer Inst. 2018 Nov 1;110(11):1178-1189 [PMID: 30380096]
  51. Eur J Nutr. 2019 Jun;58(4):1591-1602 [PMID: 29744609]
  52. J Clin Med. 2021 Jul 15;10(14): [PMID: 34300293]
  53. Genet Med. 2022 May;24(5):971-985 [PMID: 35177335]
  54. JAMA Oncol. 2023 Apr 1;9(4):481-489 [PMID: 36729438]
  55. Cancer Epidemiol. 2009 Oct;33(3-4):189-93 [PMID: 19717354]
  56. Gut. 2019 Oct;68(10):1820-1826 [PMID: 31097539]
  57. Oncotarget. 2015 Sep 22;6(28):25046-60 [PMID: 26208480]
  58. Int J Cancer. 2007 Jul 15;121(2):339-46 [PMID: 17390374]
  59. J Multimorb Comorb. 2022 Sep 15;12:26335565221110123 [PMID: 36132374]
  60. Int J Environ Res Public Health. 2020 Nov 23;17(22): [PMID: 33238496]
  61. JAMA. 2021 May 18;325(19):1965-1977 [PMID: 34003218]
  62. Cancer Epidemiol Biomarkers Prev. 2022 Apr 1;31(4):783-792 [PMID: 35247904]
  63. BMC Cancer. 2018 Jan 11;18(1):71 [PMID: 29325535]
  64. Diabetes Res Clin Pract. 2020 Jul;165:108232 [PMID: 32446797]

MeSH Term

Humans
India
Colorectal Neoplasms
Risk Factors
Incidence
Diet
Female
Male
Alcohol Drinking
Smoking
Primary Prevention
Obesity

Word Cloud

Created with Highcharts 10.0.0CRCIndiacancerfactorsburdenColorectalcountriesincidenceregionsRiskreviewEpidemiologycommonmalignancycausedeatharoundworldranksfourthincidentsexes64863cases38367deaths2022highmortalitysurvivalwaylesserdevelopedwesternfacingoveralldeclinevariousseeingincreasingtrendWithinurbanmarkedlyhigherruralincludeconsumptionredprocessedmeatfriedsugaryfoodsmokingalcoholcomorbiditiesobesitydiabetesinflammatoryboweldiseaseIBDfamilyhistoryadenomasgeneticsyndromesradiationexposurepesticidesasbestosConsumptionnutrient-richwell-balanceddietsabundantvegetablesdairyproductswholegrainsnutslegumescombinedphysicalactivityprotectiveBesidesmetforminaspirinmicronutrientsupplementsinverselyassociateddevelopmentSinceconsiderableproportionattributedmodifiableriskexecutionpopulationlevelpreventivestrategiesessentiallimitgrowingIdentifyingnecessityexploreopportunitiesprimarypreventionidentifyinghigh-riskpopulationscontrolnearfuturecolorectalcancer:specialemphasisIncidence

Similar Articles

Cited By

No available data.